Your browser doesn't support javascript.
loading
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation.
Vinnard, Christopher; Ravimohan, Shruthi; Tamuhla, Neo; Pasipanodya, Jotam; Srivastava, Shashikant; Modongo, Chawangwa; Zetola, Nicola M; Weissman, Drew; Gumbo, Tawanda; Bisson, Gregory P.
Affiliation
  • Vinnard C; Public Health Research Institute, New Jersey Medical School, Newark, New Jersey, United States of America.
  • Ravimohan S; University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.
  • Tamuhla N; Botswana-UPenn Partnership, Gaborone, Botswana.
  • Pasipanodya J; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, Texas, United States of America.
  • Srivastava S; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, Texas, United States of America.
  • Modongo C; Botswana-UPenn Partnership, Gaborone, Botswana.
  • Zetola NM; Botswana-UPenn Partnership, Gaborone, Botswana.
  • Weissman D; University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.
  • Gumbo T; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, Texas, United States of America.
  • Bisson GP; University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.
PLoS One ; 12(11): e0187624, 2017.
Article in En | MEDLINE | ID: mdl-29095954
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazinamide / Tuberculosis / HIV Infections / Anti-HIV Agents / Antitubercular Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2017 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazinamide / Tuberculosis / HIV Infections / Anti-HIV Agents / Antitubercular Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2017 Document type: Article Affiliation country: United States Country of publication: United States